| Item Type | Name |
|
Concept
|
Inflammatory Bowel Diseases
|
|
Academic Article
|
How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum?
|
|
Academic Article
|
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.
|
|
Academic Article
|
Medical therapy for inflammatory bowel disease.
|
|
Academic Article
|
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
|
|
Academic Article
|
Evolving treatment strategies for inflammatory bowel disease.
|
|
Academic Article
|
Comparative tolerability of treatments for inflammatory bowel disease.
|
|
Academic Article
|
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.
|
|
Academic Article
|
The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study.
|
|
Academic Article
|
Smoking and inflammatory bowel disease.
|
|
Academic Article
|
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
|
|
Academic Article
|
Update on medical management of inflammatory bowel disease: ulcerative colitis.
|
|
Academic Article
|
Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
|
|
Academic Article
|
Evolutionary biologic therapy for inflammatory bowel disease.
|
|
Academic Article
|
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
|
|
Academic Article
|
Factoring in growth factors for treatment of inflammatory bowel disease.
|
|
Academic Article
|
HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease.
|
|
Academic Article
|
Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage.
|
|
Academic Article
|
Treatment of inflammatory bowel disease: safety and tolerability issues.
|
|
Academic Article
|
COLAL-PRED Alizyme.
|
|
Academic Article
|
The state of the art in the management of inflammatory bowel disease.
|
|
Academic Article
|
Review article: aminosalicylates in inflammatory bowel disease.
|
|
Academic Article
|
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
|
|
Academic Article
|
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
|
|
Academic Article
|
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
|
|
Academic Article
|
Assessment, prevention and treatment of osteoporosis in inflammatory bowel disease patients: a bone of contention.
|
|
Academic Article
|
Emerging biologic therapies in inflammatory bowel disease.
|
|
Academic Article
|
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.
|
|
Academic Article
|
Semantics.
|
|
Academic Article
|
Feasibility and utility of an electronic diary to assess self-report symptoms in patients with inflammatory bowel disease.
|
|
Academic Article
|
Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.
|
|
Academic Article
|
Biologic therapy for inflammatory bowel disease comes of age.
|
|
Academic Article
|
Controversies with aminosalicylates in inflammatory bowel disease.
|
|
Academic Article
|
Aminosalicylates: old and new.
|
|
Academic Article
|
Selecting appropriate anti-TNF agents in inflammatory bowel disease.
|
|
Academic Article
|
Optimizing conventional therapies for inflammatory bowel disease.
|
|
Academic Article
|
Devolving therapeutic pyramids.
|
|
Academic Article
|
Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty.
|
|
Academic Article
|
General principles and pharmacology of biologics in inflammatory bowel disease.
|
|
Academic Article
|
Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts.
|
|
Academic Article
|
The expanding role of biologic therapy for IBD.
|
|
Academic Article
|
Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.
|
|
Academic Article
|
Inflammatory bowel disease.
|
|
Academic Article
|
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
|
|
Academic Article
|
Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
|
|
Academic Article
|
An evidence-based systematic review on medical therapies for inflammatory bowel disease.
|
|
Academic Article
|
Biologic therapy for inflammatory bowel disease comes of age.
|
|
Academic Article
|
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.
|
|
Academic Article
|
Treatment of inflammatory bowel disease: a review of medical therapy.
|
|
Academic Article
|
Disease modification in inflammatory bowel disease.
|
|
Academic Article
|
What changes in inflammatory bowel disease management can be implemented today?
|
|
Academic Article
|
Management of inflammatory bowel disease: past, present and future.
|
|
Academic Article
|
Smoking and inflammatory bowel disease in families.
|
|
Academic Article
|
Assessing response and loss of response to biological therapies in IBD.
|
|
Academic Article
|
Medical therapy of inflammatory bowel disease.
|
|
Academic Article
|
Mechanisms of disease: vitamin D and inflammatory bowel disease.
|
|
Academic Article
|
The 'tipping point' applied.
|
|
Academic Article
|
Selected individual therapeutic problems in inflammatory bowel disease.
|
|
Academic Article
|
Association between higher predicted serum vitamin D levels and reduced incidence of inflammatory bowel diseases.
|
|
Academic Article
|
Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease.
|
|
Academic Article
|
Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
|
|
Academic Article
|
Acute leukemia following inflammatory bowel disease.
|
|
Academic Article
|
Prevalence and incidence of inflammatory bowel disease in family members.
|
|
Academic Article
|
The benefits of loperamide in the treatment of patients with IBS or IBD. Introduction.
|
|
Academic Article
|
A poor view from specialty silos.
|
|
Academic Article
|
Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
|
|
Academic Article
|
Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
|
|
Academic Article
|
Inflammatory bowel disease.
|
|
Academic Article
|
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
|
|
Academic Article
|
Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease.
|
|
Academic Article
|
New steroids for IBD: progress report.
|
|
Academic Article
|
Assessing the risk of lymphomas in inflammatory bowel disease.
|
|
Academic Article
|
Inflammatory bowel disease revisited: newer drugs.
|
|
Academic Article
|
Design issues and outcomes in IBD clinical trials.
|
|
Academic Article
|
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
|
|
Academic Article
|
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
|
|
Academic Article
|
Standards for trials of therapy in inflammatory bowel disease.
|
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
|
Academic Article
|
Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD.
|
|
Academic Article
|
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
|
|
Academic Article
|
Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis.
|
|
Academic Article
|
Heading back to the trough (levels of biologics in IBD).
|
|
Academic Article
|
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease.
|
|
Academic Article
|
Comparing guidelines for the treatment of inflammatory bowel disease.
|
|
Academic Article
|
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.
|
|
Academic Article
|
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
|
|
Academic Article
|
Reply: To PMID 25311382.
|
|
Academic Article
|
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
|
|
Academic Article
|
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions.
|
|
Academic Article
|
Integrating Adolescents and Young Adults into Adult-Centered Care for IBD.
|
|
Academic Article
|
Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases.
|
|
Academic Article
|
Vitamin D Levels and Outcomes in Inflammatory Bowel Disease-Which is the Chicken and Which is the Egg?
|
|
Academic Article
|
Extrapolation and Interchangeability of Infliximab and Adalimumab in Inflammatory Bowel Disease.
|
|
Academic Article
|
The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.
|
|
Academic Article
|
Optimizing pharmacologic management of inflammatory bowel disease.
|
|
Academic Article
|
Combination Therapy for Inflammatory Bowel Disease.
|
|
Academic Article
|
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
|
|
Academic Article
|
Checkpoint Inhibitor-Induced Colitis: A New Type of Inflammatory Bowel Disease?
|
|
Academic Article
|
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
|
|
Academic Article
|
Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
|
|
Academic Article
|
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
|
|
Academic Article
|
Inflammatory Bowel Disease and the Risk of Prostate Cancer.
|
|
Academic Article
|
More Than a Tumor Marker…A Potential Role for Alpha-Feto Protein in Inflammatory Bowel Disease.
|
|
Academic Article
|
Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients.
|
|
Academic Article
|
Letter to the Editor: Patients With Inflammatory Bowel Disease Demonstrate an Inherent Lack of Psychopathology.
|
|
Academic Article
|
Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases.
|
|
Academic Article
|
The Evolving Role of Thiopurines in Inflammatory Bowel Disease.
|
|
Academic Article
|
The Evolving Role of Thiopurines in Inflammatory Bowel Disease.
|
|
Academic Article
|
Drug-Induced Colitis.
|
|
Academic Article
|
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.
|
|
Academic Article
|
Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'.
|
|
Academic Article
|
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States.
|
|
Academic Article
|
Use of thiopurines in inflammatory bowel disease: an update.
|
|
Academic Article
|
Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
|
|
Academic Article
|
Patient Perspectives on Medical Trauma Related to Inflammatory Bowel Disease.
|
|
Academic Article
|
Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
|
|
Academic Article
|
Review article: drug-induced small bowel injury.
|
|
Academic Article
|
Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).
|
|
Academic Article
|
Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy.
|
|
Academic Article
|
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
|
|
Academic Article
|
Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
|
|
Academic Article
|
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.
|
|
Academic Article
|
COVID-19 and Inflammatory Bowel Disease.
|
|
Academic Article
|
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease.
|
|
Academic Article
|
Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control study.
|
|
Academic Article
|
Persistent perineal sinus following proctocolectomy in the inflammatory bowel disease patient.
|
|
Academic Article
|
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
|